Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3

HPV-mRNA test has a higher sensitivity and a higher NPV in predicting recurrent disease, for this reason it should be used in the follow-up of patients treated with LEEP for CIN 2/3 in order to individualize the timing of check up.